Sustainability
We are building a future where people’s health, community well-being, and planet protection are at the heart of our work, driven by innovation and strong business ethics. This is our vision of responsible business.
OUR WAY OF DOING BUSINESS. For over 100 years, we have had a steady presence in European healthcare. We have developed and made available innovative medicines and therapeutic solutions to improve people's quality of life and contribute to positive societal change. Sustainability is a cornerstone of our values and our approach to responsible business: we fully embrace the Angelini Industries Group's purpose of Unwavering care, which encapsulates our commitment and responsibility toward people and the world we live in.
OUR SUSTAINABILITY JOURNEY: At Angelini Pharma, we are committed to caring for people, the community, and the planet. We work alongside our partners, exploring innovative solutions with a focus on environmental and social sustainability. In 2023, we developed an ESG Plan that is now fully aligned with Angelini Industries' 2024-2026 Sustainability Plan. Through a double materiality analysis, we have translated our company’s and stakeholders’ intentions into a structured strategy, consistent with the Group's, setting a series of concrete goals.
Sustainability Plan
Our strategy is built on four pillars — Planet, People, Patients and Communities, Ecosystems — and two enabling factors — Product and Innovation, Governance — where we aim to focus our efforts in the coming years.
The targets of the plan are structured into four areas of action, aligned with the Group's ESG strategy pillars: People, Patients - Clients and Community, Ecosystems, Planet. These four pillars are represented as interconnected and interdependent concentric circles. Enabling factors for the realization of the ESG Plan are Good Governance and Innovation.
The pillars and enabling factors
-
Planet
At Angelini Pharma, we have adopted a scientific approach to measure our impact on climate change, calculating the carbon footprint for direct, indirect, and entire value chain emissions. This has allowed us to identify critical areas and set emission reduction targets in line with the Paris Agreement.
This pillar includes objectives related to climate, water, waste, and biodiversity. -
People
Nurturing talent and developing the potential of our people is essential to our company and is key to the growth of our business and the achievement of strategic goals. Equally, we place great emphasis on creating an inclusive and safe work environment.
This pillar includes objectives related to health and safety, people’s well-being, human capital development, and inclusion. -
Patients and Communities
Putting patients at the center means offering safe, high-quality medicines, with the goal of ensuring everyone has access to our healthcare solutions. We achieve this by developing strategies and partnerships that facilitate this process. Our commitment also extends to the community through educational and social projects that support people and communities where we operate.
This pillar includes objectives related to health awareness, access to care, and local communities. -
Ecosystem
We work every day alongside universities, research centers, startups, suppliers, and customers. In this ecosystem, created to exchange knowledge, skills, and expertise, we are able to enhance the quality of research and pharmaceutical product development, offering increasingly effective therapeutic solutions.
This pillar includes objectives related to supplier relationships and responsible sourcing. -
Product & Innovation
Our Research and Development team is dedicated to identifying active ingredients, primarily in the area of Brain Health.
We also follow an Open Innovation model to collaborate with external entities and top-tier partners to achieve our goals. We have launched projects funded by European Union grants, and established partnerships with research centers, startups, and innovation ecosystems to lead the digital transformation. -
Governance
Thanks to robust sustainability governance, we are able to achieve tangible results aligned to the goals of the ESG Plan, supported by stakeholder engagement and feedback.
We have integrated sustainability into our organizational fabric, upholding high ethical and quality standards in the way we conduct business.
Our goals
-
People
Wellbeing
Engagement Rate ≥ 75
-
People
H&S
Zero serious injuries ambition for own employeers
-
People
Development
Training hours / employee > European sector average
-
Planet
Climate
100% renewable purchased electricity (Italy) -
People
Incentives
100% N-1 and N-2 MBOs linked to ESG indicators -
Patients, Clients & Community
Local Communities
+20% each year of employees volunteering for local communities
-
Planet
Climate
100% renewable purchased electricity (all Angelini Pharma) -
People, Patients, Clients & Communities
Local communities and Ecosystem
Be a recognized partner to promote transition to future skills and contribute to closing the knowledge gap in the italian system -
Patients, Clients & Community
Health awareness and access to care
Be an accelerator of awareness & de-stigmatization to unlock access to care -
Ecosystems
Partner with value chain
>90% strategic suppliers covered by Code of Conduct
-
Ecosystems
Embed responsible procurement
>90% strategic suppliers assessed
on ESG criteria (by 2027)
-
Planet
Climate
CDP A-lister on climate change
-
Planet
Climate
Reduce GHG emissions in line with Paris agreement -
Planet
Waste & circularity
-90% ind. waste to landfill -
Planet
Waste & circularity
100% new products rolled out / EcoDesign considerations -
People
Top Employer
Remain top employer in Italy and Europe and be part of top companies in Best Workplaces Europe
Our 2023 results
PLANET
First corporate carbon footprint mapping according to Greenhouse Gas Protocol standards
PEOPLE
Achievement of UNI/PdR 125:2022 Certification for gender equality in Italy.
Reaching a 50% female representation in the global workforce.
PATIENTS AND COMMUNITIES
Developed the Patient Access Framework.
Commitment to facilitating access to the best possible care for all individuals with mental health issues and epilepsy through the Headway project.
ECOSYSTEM
Expansion of collaborations with universities and research centers to strengthen R&D activities and develop projects like PharmaSea, which studies the impact of active pharmaceutical ingredients (APIs) on marine ecosystems
Sustainability report
Explore our sustainability reporting by reading our latest published report.
Our stories
-
LIFE-GREENAPI
LIFE-GREENAPI is a 3-year initiative aimed at proposing a technological shift in Active Pharmaceutical Ingredients (APIs) production to promote sustainability in the European Pharmaceutical Sector.
-
Angelini Pharma is Top Employer
Angelini Pharma confirms itself as Top Employer Europe, attesting its leadership in HR strategies in which we prioritize the well-being, growth, and satisfaction of its Angeliners.
-
Headway
Headway is a European multidisciplinary platform for strategic reflection, analysis, dialogue and comparison between the different European experiences in the management of individuals with mental and neurological disorders.
-
Research collaborations
Pharmasea is an innovative European research project led by the Marche Polytechnic University, with Angelini Pharma as a key stakeholder.
Contacts
For further inquiries, please contact our sustainability team:
